沙格雷酯联合氯吡格雷在颈动脉支架植入术后的应用效果

Abstract
Figure/Table
References (20)
Related Citation (6)

Download: PDF (412 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To discuss the clinical effectiveness and safety of Sarpogrelate combined with Clopidogrel in carotid artery stenting (CAS). Methods The clinical follow-up data of 55 cases with carotid artery stenosis treated by carotid artery stenting were retrospectively collected from January 2012 to January 2015 in the Department of Neurology and Vsculr Surgery in the First Affiliated Hospital of Hebei North University. According to treatment method, all patients were divided into Sarpogrelate combined with Clopidogrel group (observation group, 28 cases) and Aspirin combined with Clopidogrel (control group, 27 cases). Postoperative new stroke, restenosis, bleeding and mortality were compared between two groups. Results There was no significant difference with new stroke and restenosis between two groups (P > 0.05). The incidence of bleeding events in the observation group was lower than that in the control group (P < 0.05). There was no death between two groups (P > 0.05). Conclusion Sarpogrelate combined with Clopidogrel compared with Aspirin combined with Clopidogrel for antiplatelet therapy after CAS has no differences in new stroke and restenosis. Sarpogrelate is more safer and effective than Aspirin.

Key words： Sarpogrelate Clopidogrel Carotid artery stenting Application research

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Yaoyuan1 WU Xueliang2 ZOU Yu′an1

Cite this article:

ZHANG Yaoyuan1 WU Xueliang2 ZOU Yu′an1. Application effect of Sarpogrelate combined with Clopidogrel in patients after carotid artery stenting[J]. 中国医药导报, 2018, 15(20): 47-49,53.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2018/V15/I20/47

[1] 陈忠，杨耀国.对我国颈动脉狭窄性疾病治疗的探讨与展望[J].中华血管外科杂志，2017，2（2）：69-72.
[2] 辛海，白超，王洋，等.支架植入与内膜剥脱治疗颈动脉狭窄的疗效与安全性评价[J].中国组织工程研究，2013， 17（51）：8920-8927.
[3] Oka F，Ishihara H，Kato S，et al. Cerebral hemodynamic benefits after carotid artery stenting in patients with near occlusion [J]. J Vasc Surg，2013，58（6）：1512.
[4] 季蕾，蒋颖，岳春贤，等.颈动脉支架植入术治疗颈内动脉次全闭塞的临床研究[J].临床神经病学杂志，2017，30（5）：355-357.
[5] Kubacka M，Kazek G，Kotańska M，et al. Anti-aggregation effect of aroxyalkyl derivatives of 2-methoxyphenylpiperazine is due to their 5-HT2A and α2-adrenoceptor antagonistic properties. A comparison with ketanserin，sarpogrelate，prazosin，yohimbine and ARC239 [J]. Eur J Pharmacol，2018，5（818）：263-270.
[6] Squizzato A，Bellesini M，Takeda A，et al. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events [J]. Cochrane Database Syst Rev，2017，12（1）：CD005 158
[7] 郑进，石进，陈大伟，等.颈动脉支架植入术对颈内动脉狭窄患者脑血流量及脑血管反应性的影响[J].中华神经病学杂志，2017，16（8）：816-820.
[8] 王曦，于茜，陈永，等.血栓弹力图评价抗血小板治疗的疗效及相关因素分析[J].中华老年心脑血管病杂志，2017， 19（2）：144-147.
[9] Kamenskiy A，Pipinos II，Dzenis YA，et al. Effects of carotid artery stenting on arterial geometry [J]. J Am Coll Surg，2013，217（2）：251-262.
[10] 中华医学会神经病学分会.中华医学会神经病学分会脑血管病学组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2014[J].中华神经科杂志，2015，48（4）：258-273.
[11] Wang QS，Chen C，Chen XY，et al. Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease：subgroup analyses from the Fraxiparin in stroke study for the treatment of ischemic stroke（FISS-tris）study [J]. Stroke，2012，43（5）：346-349
[12] Michos ED，Ardehali R，Blumenthal RS，et al. Aspirin and clopidogrelresistance [J]. Mayo Clin Proc，2006，81（1）：518-526
[13] 中华医学会心血管病学分会，中华心血管病杂志编辑委员会.抗血小板治疗中国专家共识[J].中华心血管病杂志，2013，41（3）：183-194.
[14] Lee DH，Chun EJ，Hur JH，et al. Effect of sarpogrelate a selective 5-HT2A receptor antagonist，on characteristics of coronary artery disease in patients with type 2 diabetes [J]. Atherosclerosis，2017，257（11）：47-54.
[15] Soga Y，Shintani Y，Hamasaki T，et al. Effectiveness of Sarpogrelate after endovascular treatment for femoropo-pliteal artery disease：ESPALIER study [J]. Cardiovasc Interv Ther，2017，32（4）：325-332.
[16] 张浩，汪建中，杨云龙，等.盐酸沙格雷酯治疗下肢动脉硬化闭塞症的疗效观察-附60例临床报告[J].中国血管外科杂志：电子版，2012，4（4）：244-246.
[17] Ahn S，Lee J，Min SK，et al. SAFE（Sarpogrelate anplone in femoro-popliteal artery intervention efficacy）study：study protocol for a randomized controlled trial [J]. Trials，2017，18（1）：439-449.
[18] Shinohara Y，Nishimaru K，Sawada T，et al. Sarpogrelate-Aspirin comparative clinical study for efficacy and safety in secondary prevention of cerebral infarction（S-ACCESS）：a randomized，double-blind，Aspirin-controlled trial [J]. Stroke，2008，39（12）：1827-1833.
[19] 郭建明，谷涌泉，俞恒锡，等.沙格雷酯联合氯吡格雷在颈动脉内膜剥脱术后的应用[J].中华普通外科杂志，2013， 28（4）：292-295.
[20] Guo JM，Gu YQ，Guo LR，et al. Effects of Sarpogrelate combined with Aspirin in patients undergoing carotid endarterectomy in China：a single-center retrospective study [J]. Ann Vasc Surg，2016，8（35）：183-188.